Published in J Virol on March 01, 1992
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol (1998) 8.21
A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J Virol (1994) 2.07
Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol (2003) 1.52
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. J Virol (1994) 1.41
Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors. J Virol (1997) 1.40
Improved self-inactivating retroviral vectors derived from spleen necrosis virus. J Virol (1994) 1.11
Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy. J Virol (1996) 1.06
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery. Genet Vaccines Ther (2004) 0.97
Evaluation of residual promoter activity in γ-retroviral self-inactivating (SIN) vectors. Mol Ther (2011) 0.87
DNA recombination is sufficient for retroviral transduction. Proc Natl Acad Sci U S A (1995) 0.86
Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors. Virol J (2006) 0.82
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. BMC Mol Biol (2009) 0.78
The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts. J Biol Chem (2014) 0.77
An internal deletion enhances the transcriptional activity of a recombinant retrovirus in hematopoietic cells in vivo. J Virol (1994) 0.77
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82
A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance. Mol Gen Genet (1979) 19.37
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol (1986) 16.65
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A (1988) 9.35
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol (1988) 7.87
Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol (1979) 7.69
Retroviral recombination and reverse transcription. Science (1990) 6.27
High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc Natl Acad Sci U S A (1984) 5.89
Negative regulation of viral enhancers in undifferentiated embryonic stem cells. Cell (1985) 5.88
Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol Cell Biol (1983) 4.96
Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J Virol (1988) 4.88
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci U S A (1990) 4.72
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 4.29
Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J Virol (1984) 4.17
High fidelity DNA synthesis by the Thermus aquaticus DNA polymerase. Nucleic Acids Res (1990) 4.12
Prospects for human gene therapy. Science (1984) 3.93
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature (1988) 3.18
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J Virol (1989) 2.86
A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J Virol (1988) 2.62
Progress toward human gene therapy. Science (1989) 2.26
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13
Retroviral vector system for the study of cDNA gene formation. Mol Cell Biol (1988) 1.50
Progress toward human gene therapy. Blood (1990) 1.30
Comparison of promoter suppression in avian and murine retrovirus vectors. Nucleic Acids Res (1986) 1.17
Retroviral transduction of oncogenic sequences involves viral DNA instead of RNA. Proc Natl Acad Sci U S A (1988) 1.17
Transduction of cellular neo mRNA by retrovirus-mediated recombination. J Virol (1990) 1.08
Retroviral-mediated gene transfer. Prog Nucleic Acid Res Mol Biol (1990) 1.02
Evidence that retroviral transduction is mediated by DNA not by RNA. Proc Natl Acad Sci U S A (1990) 1.02
cDNA genes formed after infection with retroviral vector particles lack the hallmarks of natural processed pseudogenes. Mol Cell Biol (1990) 0.97
Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes. J Virol (1990) 0.95
Retroviral gene transfer: applications to human therapy. Prog Clin Biol Res (1990) 0.92
Generation of competent virus in the REV helper cell line C3. Virology (1987) 0.90
Gene therapy for genetic diseases. Cancer Invest (1989) 0.90
Gene therapy: a new approach for the treatment of genetic disorders. Clin Pharmacol Ther (1990) 0.80
RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Retroviral recombination and reverse transcription. Science (1990) 6.27
RNA-directed DNA synthesis and RNA tumor viruses. Adv Virus Res (1972) 6.11
Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature (1980) 5.95
Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene. Proc Natl Acad Sci U S A (1982) 5.56
Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol Cell Biol (1983) 4.96
Structure, variation and synthesis of retrovirus long terminal repeat. Cell (1981) 4.90
The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature (1984) 4.89
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc Natl Acad Sci U S A (1984) 4.81
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci U S A (1990) 4.72
Studies on carcinogenesis by avian sarcoma viruses. VI. Differential multiplication of uninfected and of converted cells in response to insulin. J Cell Physiol (1967) 4.55
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 4.29
Mechanism of cell transformation by RNA tumor viruses. Annu Rev Microbiol (1971) 4.24
Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel. J Virol (1984) 4.17
Carcinogenesis by RNA sarcoma viruses. XII. A quantitative study of infection of rat cells in vitro by avian sarcoma viruses. Virology (1970) 3.90
Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell (1981) 3.80
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Origin of retroviruses from cellular moveable genetic elements. Cell (1980) 3.67
Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity. J Virol (1973) 3.62
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus. J Virol (1980) 3.53
Circles with two tandem LTRs are precursors to integrated retrovirus DNA. Cell (1984) 3.45
Stimulation by serum of multiplication of stationary chicken cells. J Cell Physiol (1971) 3.41
Cell cycle-dependent activation of rous sarcoma virus-infected stationary chicken cells: avian leukosis virus group-specific antigens and ribonucleic acid. J Virol (1972) 3.35
A DNA-depenent DNA polymerase and a DNA endonuclease in virions of Rous sarcoma virus. Nature (1970) 3.31
Formation and structure of infectious DNA of spleen necrosis virus. J Virol (1977) 3.29
Replication of reticuloendotheliosis viruses in cell culture: acute infection. J Virol (1974) 3.17
High-efficiency ligation and recombination of DNA fragments by vertebrate cells. Science (1983) 2.99
Comparison of Rous sarcoma virus-specific deoxyribonucleic acid polymerases in virions of Rous sarcoma virus and in Rous sarcoma virus-infected chicken cells. J Virol (1971) 2.97
Function of the retrovirus long terminal repeat. Cell (1982) 2.89
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J Virol (1989) 2.86
Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J Virol (1974) 2.86
Infectious rous sarcoma virus and reticuloendotheliosis virus DNAs. J Virol (1974) 2.77
Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J Virol (1977) 2.71
Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science (1993) 2.64
Reticuloendotheliosis virus nucleic acid sequences in cellular DNA. J Virol (1974) 2.55
Characterization of reticuloendotheliosis virus strain T DNA and isolation of a novel variant of reticuloendotheliosis virus strain T by molecular cloning. J Virol (1981) 2.49
Lack of serological relationship among DNA polymerases of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken cells. J Virol (1973) 2.46
Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector. Nature (1982) 2.38
The partial purification from calf serum of a fraction with multiplication-stimulating activity for chicken fibroblasts in cell culture and with non-suppressible insulin-like activity. J Cell Physiol (1972) 2.37
Infectious and noninfectious recombinant clones of the provirus of SNV differ in cellular DNA and are apparently the same in viral DNA. Cell (1980) 2.35
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol (1979) 2.33
The DNA provirus hypothesis. Science (1976) 2.31
Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection. J Virol (1982) 2.26
Studies on carcinogenesis by avian sarcoma viruses. 8. Glycolysis and cell multiplication. Int J Cancer (1968) 2.25
Spontaneous changes in nucleotide sequence in proviruses of spleen necrosis virus, an avian retrovirus. Proc Natl Acad Sci U S A (1982) 2.16
A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A (1987) 2.13
Cell killing by avian leukosis viruses. J Virol (1981) 2.10
Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol Cell Biol (1986) 2.08
v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J Virol (1988) 2.08
5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J Virol (1992) 2.03
Light inactivation of focus formation by chicken embryo fibroblasts infected with avian sarcoma virus in the presence of 5-bromodeoxyuridine. Nature (1970) 2.02
Lack of infectivity of the endogenous avian leukosis virus-related genes in the DNA of uninfected chicken cells. J Virol (1976) 1.99
Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell (1986) 1.96
A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts. J Cell Physiol (1973) 1.93
The protovirus hypothesis: speculations on the significance of RNA-directed DNA synthesis for normal development and for carcinogenesis. J Natl Cancer Inst (1971) 1.93
Hybridization of Rous sarcoma virus deoxyribonucleic acid polymerase product and ribonucleic acids from chicken and rat cells infected with Rous sarcoma virus. J Virol (1972) 1.91
Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol Cell Biol (1989) 1.87
Multiplication-stimulating activity for chicken embryo fibroblasts from rat liver cell conditioned medium: a family of small polypeptides. J Cell Physiol (1973) 1.87
Sites of integration of reticuloendotheliosis virus DNA in chicken DNA. Proc Natl Acad Sci U S A (1978) 1.86
Insertion of several different DNAs in reticuloendotheliosis virus strain T suppresses transformation by reducing the amount of subgenomic mRNA. J Virol (1986) 1.83
The mechanism of carcinogenesis by avian sarcoma viruses. 1. Cell multiplication and differentiation. J Natl Cancer Inst (1965) 1.82
The cellular and molecular biology of RNA tumor viruses, especially avian leukosis-sarcoma viruses, and their relatives. Adv Cancer Res (1974) 1.81
Instability of large direct repeats in retrovirus vectors. J Virol (1987) 1.78
Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J Virol (1994) 1.76
Enzymes and nucleotides in virions of Rous sarcoma virus. J Virol (1971) 1.74
Reverse transcriptases. Retrons in bacteria. Nature (1989) 1.74
High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters. J Virol (1984) 1.73
No apparent nucleotide sequence specificity in cellular DNA juxtaposed to retrovirus proviruses. Proc Natl Acad Sci U S A (1980) 1.72
DNA of noninfectious and infectious integrated spleen necrosis virus (SNV) is colinear with unintegrated SNV DNA and not grossly abnormal. Cell (1979) 1.71
DNA ligase and exonuclease activities in virions of rous sarcoma virus. Nat New Biol (1971) 1.71
Retrovirus recombination depends on the length of sequence identity and is not error prone. J Virol (1994) 1.70
Spontaneous variation and synthesis in the U3 region of the long terminal repeat of an avian retrovirus. J Virol (1982) 1.69
Substitution of 5' helper virus sequences into non-rel portion of reticuloendotheliosis virus strain T suppresses transformation of chicken spleen cells. Cell (1982) 1.69
Replication of reticuloendotheliosis viruses in cell culture: chronic infection. J Gen Virol (1975) 1.68
Specific serological relationships among partially purified DNA polymerases of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and avian cells. J Virol (1974) 1.61
One retroviral RNA is sufficient for synthesis of viral DNA. J Virol (1994) 1.60
Expression of complete chicken thymidine kinase gene inserted in a retrovirus vector. Mol Cell Biol (1984) 1.58
Infectious DNA of spleen necrosis virus is integrated at a single site in the DNA of chronically infected chicken fibroblasts. Proc Natl Acad Sci U S A (1977) 1.58
A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J (1994) 1.58
Sites of integration of infectious DNA of avian reticuloendotheliosis viruses in different avian cellular DNAs. Cell (1978) 1.57
The RNA tumor viruses--background and foreground. Proc Natl Acad Sci U S A (1972) 1.56
Ribonuclease-sensitive deoxyribonucleic acid polymerase activity in uninfected rat cells and rat cells infected with Rous sarcoma virus. J Virol (1971) 1.54
On the origin of RNA tumor viruses. Annu Rev Genet (1974) 1.53
Recombination of transfected DNAs in vertebrate cells in culture. Proc Natl Acad Sci U S A (1984) 1.50
Retroviral vector system for the study of cDNA gene formation. Mol Cell Biol (1988) 1.50
Endogenous RNA-directed DNA polymerase activity in uninfected chicken embryos. Proc Natl Acad Sci U S A (1972) 1.49
Control by factors in serum of multiplication of uninfected cells and cells infected and converted by avian sarcoma viruses. Wistar Inst Symp Monogr (1967) 1.46
Effect of gamma radiation on retroviral recombination. J Virol (1992) 1.43
Expression from an internal AUG codon of herpes simplex thymidine kinase gene inserted in a retrovirus vector. Mol Cell Biol (1984) 1.42
The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters. Oncogene (1988) 1.41
Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol (1995) 1.41
Studies on carcinogenesis by avian sarcoma viruses. 3. The differential effect of serum and polyanions on multiplication of uninfected and converted cells. J Natl Cancer Inst (1966) 1.41
Structure and expression of c-rel, the cellular homolog to the oncogene of reticuloendotheliosis virus strain T. J Virol (1983) 1.40